Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E86.
Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi REM, Corcione F. Worldwide burden of colorectal cancer: a review. Updat Surg. 2016;68(1):7–11.
Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):997.
Vardanjani HM, Haghdoost A, Bagheri-Lankarani K, Hadipour M. Estimation and projection of prevalence of colorectal cancer in Iran, 2015–2020. Adv Biomed Res. 2018;30(7):20.
Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S. Colorectal cancer in Iran: molecular epidemiology and screening strategies. J Cancer Epidemiol. 2015;2015:643020.
Chew M-H, Koh P-K, Ng K-H, Eu K-W. Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution. Int J Color Dis. 2009;24(9):1075–83.
de Sousa JB, Souza CS, Fernandes MB, de Castro DL, de Almeida RM, dos Santos ACN, et al. Do young patients have different clinical presentation of colorectal cancer causing delay in diagnosis? Int J Color Dis. 2014;29(4):519–27.
You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012;172(3):287–9.
Kasi PM, Shahjehan F, Cochuyt J, Li Z, Colibaseanu D, Merchea A. Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer. 2018;18(1):e87–95.
Foroutan M, Rahimi N, Tabatabaeifar M, Darvishi M, Hashemi M, Hossein-Panah F, et al. Clinical features of colorectal cancer in Iran: a 15-year review. J Dig Dis. 2008;9(4):225–7.
Silla IO, Rueda D, Rodríguez Y, García JL, de la Cruz VF, Perea J. Early-onset colorectal cancer: a separate subset of colorectal cancer. World J Gastroenterol: WJG. 2014;20(46):17288.
Zhao L, Bao F, Yan J, Liu H, Li T, Chen H, et al. Poor prognosis of young patients with colorectal cancer: a retrospective study. Int J Color Dis. 2017;32(8):1147–56.
Jones HG, Radwan R, Davies M, Evans M, Khot U, Chandrasekaran T, et al. Clinicopathological characteristics of colorectal cancer presenting under the age of 50. Int J Color Dis. 2015;30(4):483–9.
Schellerer VS, Merkel S, Schumann SC, Schlabrakowski A, Förtsch T, Schildberg C, et al. Despite aggressive histopathology survival is not impaired in young patients with colorectal cancer. Int J Color Dis. 2012;27(1):71–9.
McKay A, Donaleshen J, Helewa RM, Park J, Wirtzfeld D, Hochman D, et al. Does young age influence the prognosis of colorectal cancer: a population-based analysis. World J Surg Oncol. 2014;12(1):370.
Campos FG. Colorectal cancer in young adults: a difficult challenge. World J Gastroenterol. 2017;23(28):5041.
Punt CJA, Buyse M, Köhne CH, Hohenberger P, Labianca R, Schmoll HJ, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99(13):998–1003.
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.
Yeo S, Chew M, Koh P, Tang C. Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases. Tech Coloproctol. 2013;17(6):653–61.
Fu J, Yang J, Tan Y, Jiang M, Wen F, Huang Y, et al. Young patients (≤ 35years old) with colorectal cancer have worse outcomes due to more advanced disease: a 30-year retrospective review. Medicine. 2014;93(23):e135.
Kam M, Eu K, Barben C, Seow-Choen F. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Color Dis. 2004;6(3):191–4.
Chan K, Dassanayake B, Deen R, Wickramarachchi R, Kumarage S, Samita S, et al. Young patients with colorectal cancer have poor survival in the first twenty months after operation and predictable survival in the medium and long-term: analysis of survival and prognostic markers. World J Surg Oncol. 2010;8(1):82.
Atkin W, Northover J, Cuzick J, Whynes D. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341(8847):736–40.
Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, et al. NCCN guidelines insights: colorectal cancer screening, version 1.2018. J Natl Compr Cancer Netw. 2018;16(8):939–49.
Aryaie M, Roshandel G, Semnani S, Asadi-Lari M, Aarabi M, Vakili MA, et al. Predictors of colorectal cancer survival in Golestan, Iran: a population-based study. Epidemiol Health. 2013;35:e2013004.
Zhao M, Liu H, Tang Y, Meng X, Yu J, Wang Q, et al. Clinicopathologic features and prognostic factors for patients with colorectal cancer who are 75 years and older. Oncotarget. 2017;8(45):80002.
Wang R, Wang M-J, Ping J. Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988–2011). Medicine. 2015;94(35):e1402.
Hara M, Sato M, Takahashi H, Takayama S, Takeyama H. Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year. Surg Today. 2011;41(10):1357–62.
Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479–516.